Regulatable Gene Expression Systems for Gene Therapy
Journal:
Current Gene Therapy
Volume:
6
Page:
421-438
Author(s):
Nuria Vilaboa and Richard Voellmy
Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Journal:
Current Gene Therapy
Volume:
6
Page:
505-533
Author(s):
Maite Verreault, Murray S. Webb, Euan C. Ramsay and Marcel B. Bally
Contrast Enhanced Ultrasonography for Focal Liver Lesions Characterization: Clinical Perspective
Journal:
Current Medical Imaging
Volume:
2
Page:
373-383
Author(s):
Michele Bertolotto, Tommaso Vincenzo Bartolotta, Loretta Calderan, Stefano Cernic, Ada Mandic and Maria Assunta Cova
Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2833-2848
Author(s):
Mary A. Bewick and Robert M. Lafrenie
The Role of Matrix Metalloproteinase Inhibitors in Ischemia-Reperfusion Injury in the Liver
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2923-2934
Author(s):
S. Viappiani, M. Sariahmetoglu and R. Schulz
Rho GTPase Activating Proteins in Cancer Phenotypes
Journal:
Current Protein & Peptide Science
Volume:
7
Page:
355-365
Author(s):
Raj P. Kandpal
Histone Deacetylase Inhibitors as Potent Modulators of Cellular Contacts
Journal:
Current Drug Targets
Volume:
7
Page:
773-787
Author(s):
Mathieu Vinken, Papeleu Peggy, Rogiers Vera and Vanhaecke Tamara
HSV-1 Based Amplicon Vectors as an Alternative System for the Expression of Functional HCV Proteins
Journal:
Current Gene Therapy
Volume:
6
Page:
393-398
Author(s):
Eliza Tsitoura, Urania Georgopoulou and Penelope Mavromara
Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
163-170
Author(s):
Lars P. Jordheim, Carlos M. Galmarini and Charles Dumontet
Recent Patents Therapeutic Agents for Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
255-284
Author(s):
Xun Li and Wenfang Xu